NVCR
$15.71+5.51%
NovoCure LimitedStock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.008% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
NVCR financial statements
The full income statement, balance sheet, and cash-flow statement for NovoCure Limited (NVCR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 108.2M2024-09 108.2M2024-12 109.9M2025-03 111.5M2025-06 111.8M2025-09 112.0M2025-12 113.8M2026-03 115.8M2026-06 116.4M+7.6% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 655M+8.3% | 605M+18.8% | 509M-5.3% | 538M+0.5% | 535M+8.2% | |
| 488M+4.4% | 468M+22.8% | 381M-9.9% | 423M+0.7% | 420M+8.3% | ||
| Cost of revenue | 167M+21.6% | 137M+6.9% | 128M+11.7% | 115M-0.0% | 115M+7.9% | |
| 642M+0.6% | 639M+4.0% | 614M+19.8% | 512M+10.3% | 464M+29.9% | ||
| Research & development | 225M+7.1% | 210M-6.0% | 223M+8.2% | 206M+2.4% | 201M+52.5% | |
| Selling, general & administrative | 178M-6.4% | 190M+15.7% | 164M+23.6% | 133M+5.3% | 126M+17.4% | |
| General & administrative | 178M-6.4% | 190M+15.7% | 164M+23.6% | 133M+5.3% | 126M+17.4% | |
| Selling & marketing | 240M+0.4% | 239M+5.4% | 227M+30.6% | 174M+26.7% | 137M+16.1% | |
| Operating income | -154M+9.8% | -170M+26.8% | -233M-160.1% | -89.5M-101.9% | -44.3M-245.8% | |
| Interest expense | 22.2M+90.5% | 11.7M+137.7% | 4.91M-39.5% | 8.11M-8.2% | 8.84M-51.0% | |
| Interest & investment income | 12.9M-43.3% | 22.7M+15.7% | 19.6M+79.2% | 11.0M+1285.7% | 791K-55.7% | |
| Net interest income | — | — | — | 7.68M | — | |
| Pre-tax income | -136M-3.9% | -131M+31.6% | -192M-134.3% | -81.8M-57.2% | -52.1M-387.7% | |
| Income tax | -23.0K-100.1% | 37.5M+144.8% | 15.3M+43.2% | 10.7M+70.3% | 6.28M+467.9% | |
| -136M+19.2% | -169M+18.6% | -207M-123.7% | -92.5M-58.6% | -58.4M-394.6% | ||
| Net income to common | -136M+19.2% | -169M+18.6% | -207M-123.7% | -92.5M-58.6% | -58.4M-394.6% | |
| -$1.22+21.8% | -$1.56+20.0% | -$1.95-121.6% | -$0.88-57.1% | -$0.56-411.1% | ||
| EPS (basic) | -$1.22+21.8% | -$1.56+20.0% | -$1.95-121.6% | -$0.88-57.1% | -$0.56-380.0% | |
| Weighted-avg shares (basic) | 111M+3.4% | 108M+1.4% | 106M+1.7% | 105M+1.2% | 103M+2.5% | |
| Weighted-avg shares (diluted) | 111M+3.4% | 108M+1.4% | 106M+1.7% | 105M+1.2% | 103M-5.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 647M-41.6% | 1.11B+7.0% | 1.03B-6.9% | 1.11B+3.5% | 1.07B+7.4% | ||
| Cash & equivalents | 93.5M-42.9% | 164M-32.0% | 241M+108.8% | 115M-44.8% | 209M-11.0% | |
| Accounts receivable | 89.4M+20.5% | 74.2M+21.2% | 61.2M-29.0% | 86.3M-7.8% | 93.6M-3.2% | |
| Inventory | 41.1M+17.2% | 35.1M-8.0% | 38.2M+29.9% | 29.4M+20.3% | 24.4M-10.9% | |
| Prepaid expenses | 9.66M+33.8% | 7.22M+6.4% | 6.78M+9.5% | 6.20M+31.5% | 4.71M+18.9% | |
| 804M-35.2% | 1.24B+8.3% | 1.15B-3.8% | 1.19B+4.6% | 1.14B+8.3% | ||
| Property, plant & equipment | 77.6M-0.1% | 77.7M+50.9% | 51.5M+57.5% | 32.7M+44.0% | 22.7M+99.1% | |
| Operating lease right-of-use | 47.3M+74.5% | 27.1M-22.1% | 34.8M+47.6% | 23.6M+29.2% | 18.3M-3.9% | |
| Other non-current assets | 10.6M-27.5% | 14.6M+4.3% | 14.0M+25.6% | 11.2M-7.7% | 12.1M+10.8% | |
| Total non-current assets | 158M+17.4% | 134M+20.1% | 112M+39.4% | 80.1M+21.4% | 66.0M+25.6% | |
| 223M-70.5% | 756M+322.3% | 179M+12.8% | 159M+11.3% | 143M+25.5% | ||
| Accounts payable | 122M+16.3% | 105M+11.3% | 94.4M+10.8% | 85.2M+17.4% | 72.6M+35.3% | |
| Deferred revenue | 15.9M+12.1% | 14.2M-12.3% | 16.2M-10.0% | 18.0M | — | |
| Current lease liability | 11.7M+47.4% | 7.91M-3.8% | 8.22M+41.7% | 5.80M-13.2% | 6.68M+3.1% | |
| 464M-47.3% | 881M+12.4% | 784M+4.4% | 750M+2.9% | 729M+26.7% | ||
| Long-term debt | 195M+100.5% | 97.3M-82.9% | 569M+0.6% | 566M+0.6% | 562M+30.8% | |
| Deferred revenue (non-current) | — | — | 0.00-100.0% | 2.88M-55.6% | 6.48M-46.6% | |
| Non-current lease liability | 41.6M+108.5% | 20.0M-27.2% | 27.4M+46.1% | 18.8M+44.4% | 13.0M-9.1% | |
| Operating lease liability (total) | 53.3M+91.2% | 27.9M-21.8% | 35.6M+45.1% | 24.6M+24.8% | 19.7M-5.3% | |
| Other non-current liabilities | — | 18.0K+0.0% | 18.0K-87.8% | 148K-10.8% | 166K-50.7% | |
| Total non-current liabilities | 241M+93.7% | 124M-79.5% | 605M+2.2% | 592M+0.9% | 586M+27.0% | |
| 340M-5.5% | 360M-0.6% | 362M-17.8% | 441M+7.5% | 410M-13.9% | ||
| Common stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 1.63B+7.5% | 1.52B+12.3% | 1.35B+10.8% | 1.22B+11.1% | 1.10B-1.1% | |
| Retained earnings | -1.29B-11.8% | -1.15B-17.1% | -986M-26.6% | -778M-13.5% | -686M-8.7% | |
| Accumulated other comprehensive income | -3.44M+37.4% | -5.50M-0.6% | -5.47M-124.8% | -2.43M+23.2% | -3.17M+17.3% | |
| Total liabilities & equity | 804M-35.2% | 1.24B+8.3% | 1.15B-3.8% | 1.19B+4.6% | 1.14B+8.3% | |
| Common shares issued | 112M+3.7% | 109M+1.3% | 107M+1.9% | 105M+1.0% | 104M+1.6% | |
| Common shares outstanding | 112M+3.7% | 109M+1.3% | 107M+1.9% | 105M+1.0% | 104M+1.6% | |
| Shares outstanding (cover) | 114M+3.5% | 110M+2.6% | 107M+1.6% | 105M+1.0% | 104M+2.0% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -49.0M-85.9% | -26.4M+64.0% | -73.3M-338.2% | 30.8M-62.8% | 82.8M-16.5% | ||
| Depreciation & amortization | 14.7M+30.4% | 11.2M+2.4% | 11.0M+3.2% | 10.6M+3.6% | 10.3M+12.0% | |
| Share-based compensation | 105M-34.5% | 160M+38.4% | 116M+8.1% | 107M+12.7% | 94.9M+25.3% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in receivables | — | — | — | -2.55M+51.7% | -5.27M-117.4% | |
| Change in inventory | 5.67M+320.7% | -2.57M-128.8% | 8.92M+105.4% | 4.34M+274.9% | -2.48M-184.6% | |
| 437M+411.8% | -140M-176.2% | 184M+231.6% | -140M+3.4% | -145M+69.4% | ||
| Capital expenditure | 26.6M-37.8% | 42.9M+58.2% | 27.1M+26.9% | 21.4M-11.6% | 24.2M+61.5% | |
| Free cash flow | -75.7M-9.3% | -69.2M+31.1% | -100M-1165.0% | 9.43M-83.9% | 58.6M-30.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -451M-599.7% | 90.3M+472.1% | 15.8M+1.9% | 15.5M-39.7% | 25.7M-94.2% | ||
| Long-term debt issued | 100.0M+3.2% | 96.9M | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 561M+4244.0% | 12.9M+129030.0% | 10.0K-64.3% | 28.0K+7.7% | 26.0K-100.0% | |
| Common stock issued | 3.66M-11.9% | 4.15M-6.0% | 4.42M-15.5% | 5.22M+14.9% | 4.55M+34.9% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 394K+326.4% | -174K-232.8% | 131K+235.1% | -97.0K+48.4% | -188K-176.1% | |
| Net change in cash | -62.7M+18.0% | -76.5M-160.3% | 127M+235.1% | -93.8M-156.5% | -36.6M-154.8% | |
| Interest paid | 13.4M+73.8% | 7.71M+128466.7% | 6.00K-85.4% | 41.0K-59.4% | 101K-98.8% | |
| Income taxes paid | 30.7M+30.7% | 23.5M+71.7% | 13.7M+149.4% | 5.48M+76.2% | 3.11M+195.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.47B-55.1% | 3.28B+105.3% | 1.60B-79.3% | 7.70B-1.8% | 7.84B-55.8% | |
| P/S | 2.2×-58.5% | 5.4×+71.0% | 3.2×-77.7% | 14.2×-3.2% | 14.7×-59.1% | |
| P/B | 4.3×-52.5% | 9.1×+124.4% | 4.1×-76.6% | 17.3×-9.5% | 19.1×-48.6% | |
| P/FCF | — | — | — | 390.8×+192.0% | 133.8×-36.4% | |
| FCF yield | — | — | — | 0.26%-65.8% | 0.75%+57.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: NVCR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all NVCR filings on SEC EDGAR → Not investment advice.